Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neoplasms 47Breast Neoplasms 32Colorectal Neoplasms 28Prostatic Neoplasms 27Lung Neoplasms 16Hematopoietic and Lymphatic System Neoplasm 12Hematologic Neoplasms 12Ovarian Neoplasms 11Uterine Cervical Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Lymphoma 7Leukemia 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Depression 6Rectal Neoplasms 5Pancreatic Neoplasms 5Urinary Bladder Neoplasms 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Malignant Solid Neoplasm 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Gastrointestinal Neoplasms 4Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Advanced Cancer 4

Interventions

Brentuximab Vedotin 21Cyclophosphamide 20fludarabine 16Rituximab 13Lenalidomide 13Dexamethasone 12fludarabine phosphate 10Melphalan 10Busulfan 10Mycophenolic Acid 9pirtobrutinib 7dacetuzumab 7Whole-Body Irradiation 7Tacrolimus 7Bortezomib 7Doxorubicin 6Azacitidine 6ruxolitinib 5Vincristine 5Prednisone 5Imatinib Mesylate 5Bone Marrow Transplantation 5ponatinib 4pomalidomide 4Mesna 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Blood Specimen Collection 4Bendamustine Hydrochloride 4venetoclax 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Diseases × Interviews as Topic × Clear all
NCT03272789 2019-01-23

REBOND

Institut Paoli-Calmettes

Phase NA Unknown
32 enrolled

Hematologic Diseases, Neoplasms

NCT00909207 2014-07-14

Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing

M.D. Anderson Cancer Center

Completed
20 enrolled

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡